Investment Counsel Co Of Nevada »

ResMed shares owned by Investment Counsel Co Of Nevada

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Investment Counsel Co Of Nevada from 13F filings

Historical chart of Investment Counsel Co Of Nevada investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Investment Counsel Co Of Nevada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Investment Counsel Co Of Nevada

Quarter filed Position value Share count Share price at filing
2025-09-30 $219k 800 273.73
2025-06-30 $206k 800 258.00
2025-03-31 $179k 800 223.85
2024-12-31 $183k 800 228.69

More positions owned by Investment Counsel Co Of Nevada

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Johnson & Johnson (JNJ)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Esg Awr Us Agrgt (EAGG)
Dbx Etf Tr Xtrackrs S&p 500 (SNPE)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Large Cap Etf (VV)
Ge Aerospace Com New (GE)
Tyra Biosciences (TYRA)
Vanguard Index Fds Small Cp Etf (VB)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ge Vernova (GEV)
Goldman Sachs Etf Tr S&p 500 Premium (GPIX)

View all positions for Investment Counsel Co Of Nevada

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
Charles Schwab Investment Management
Legal & General Group
Ubs Global Asset Management Americas
UBS Group
FMR
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding ResMed